Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
-$46.47K-16.0%
HTF
Heartflow, Inc.HTFL
-$981K-10.5%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
-$270K-83.7%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Ondas, Inc. logo
Ondas, Inc.ONDS
-$593K-106%
APO
Apogee EnterprisesAPOG
-$3.43M+5.8%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$6.34B+1,198%
Enterprise value$6.29B+1,379%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other non-current assets(60)
Accounts payable(493)83
Accrued expenses and other current liabilities(1,304)2,317
Operating lease liability(125)(21)
Related party accounts payable and other current liabilities2,995(5,205)
Net cash used in operating activities(23,578)(20,869)
Cash flows from investing activities:
Purchases of property and equipment(73)(13)

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities?
Oruka Therapeutics, Inc. (ORKA) reported short- and long-term operating lease liabilities of -$125K in Q1 2026.
How has Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities decreased by 495.2% year-over-year, from -$21K to -$125K.
What does short- and long-term operating lease liabilities mean?
Measures the net change in the present value of future lease payments for operating assets. This metric is essential for understanding the company's long-term fixed commitments and the impact of lease accounting standards on the balance sheet.

Ask your AI about Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude